Duker Jay S. — SEC Form 4 filings

SEC reporting owner CIK 1630864. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-01-09 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EyePoint, Inc. (EYPT)President and CEO, Director151 leg · 1,500 sh · $19,72454

Form 4 filings — Duker Jay S.

FiledFormIssuerReported transactionsSource
2026-07-144EyePoint, Inc. (EYPT)Option exercise (M): 16,667 @ $0 · Tax withholding (F): 8,059 @ $14.72 · Option exercise (M): 16,667 (derivative) @ $0EDGAR
2026-03-244EyePoint, Inc. (EYPT)Other (J): 76,766 @ $13.11 · Other (J): 76,766 @ $13.11 · Other (J): 52,500 (derivative) @ $8.75 · Other (J): 52,500 (derivative) @ $8.75 · Other (J): 97,500 (derivative) @ $9.57 · Other (J): 97,500 (derivative) @ $9.57EDGAR
2026-03-164EyePoint, Inc. (EYPT)Purchase (P): 1,500 @ $13.15EDGAR
2026-01-074EyePoint, Inc. (EYPT)Option exercise (M): 20,793 @ $0 · Tax withholding (F): 10,054 @ $16.86 · Option exercise (M): 20,793 (derivative) @ $0EDGAR
2026-01-064EyePoint, Inc. (EYPT)Option exercise (M): 65,000 @ $0 · Tax withholding (F): 23,447 @ $17.48 · Option exercise (M): 30,000 @ $0 · Tax withholding (F): 14,505 @ $17.43 · Grant/award (A): 165,000 (derivative) @ $0 · Grant/award (A): 331,000 (derivative) @ $0 · +2 moreEDGAR
2025-07-114EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 16,667 @ $0 · Tax withholding (F): 7,688 @ $11.06 · Option exercise (M): 16,667 (derivative) @ $0EDGAR
2025-06-254EyePoint Pharmaceuticals, Inc. (EYPT)Other (J): 56,665 @ $8.21EDGAR
2025-03-204EyePoint Pharmaceuticals, Inc. (EYPT)Other (J): 20,000 @ $6.16EDGAR
2025-02-114EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 7,000 @ $0 · Tax withholding (F): 2,055 @ $6.50 · Option exercise (M): 7,000 (derivative) @ $0EDGAR
2025-01-074EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 30,000 @ $0 · Tax withholding (F): 10,007 @ $8.26 · Option exercise (M): 20,794 @ $0 · Tax withholding (F): 6,108 @ $8.68 · Grant/award (A): 195,000 (derivative) @ $0 · Grant/award (A): 390,000 (derivative) @ $0 · +2 moreEDGAR
2024-07-124EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 16,666 @ $0 · Tax withholding (F): 8,059 @ $8.69 · Option exercise (M): 16,666 (derivative) @ $0EDGAR
2024-02-284EyePoint Pharmaceuticals, Inc. (EYPT)Gift (G): 2,500 @ $0 · Gift (G): 2,500 @ $0EDGAR
2024-02-224EyePoint Pharmaceuticals, Inc. (EYPT)Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0EDGAR
2024-02-134EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 7,000 @ $0 · Option exercise (M): 4,967 @ $0 · Tax withholding (F): 2,075 @ $28.80 · Tax withholding (F): 1,458 @ $28.80 · Option exercise (M): 4,967 (derivative) @ $0 · Option exercise (M): 7,000 (derivative) @ $0EDGAR
2024-01-094EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 20,793 @ $0 · Tax withholding (F): 6,528 @ $20.40 · Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 · Option exercise (M): 20,793 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1630864 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →